Literature DB >> 12610739

Intrarectal pharmacokinetics of two formulations of quinine in children with falciparum malaria.

H Barennes1, H Sterlingot, N Nagot, H Meda, M Kaboré, M Sanou, B Nacro, P Bourée, E Pussard.   

Abstract

OBJECTIVE: To compare the intrarectal bioavailabilities of two parenteral formulations of quinine most available in French- (Cinchona alkaloid mixture) and English (hydrochloride salt) -speaking areas of Africa.
METHODS: The pharmacokinetics of quinine was investigated in four groups of 12 children with acute Plasmodium falciparum malaria receiving 8 mg/kg quinine base every 8 h either as hydrochloride salt or Cinchona alkaloid mixture by a slow 4-h intravenous infusion or intrarectal administration. Body temperature and parasitaemia were monitored, and blood quinine concentrations were measured by means of high-performance liquid chromatography.
RESULTS: At 72 h, all the children were aparasitaemic and apyretic. Quinine C(max) values were higher after intravenous infusion of the hydrochloride salt and Cinchona alkaloid mixture (6.9+/-1.9 micro g/ml and 5.2+/-1.3 micro g/ml) than after intrarectal administration (3.5+/-1.4 micro g/ml and 3.1+/-1.6 micro g/ml), but t(max) values were similar (3.6+/-1.5, 4.2+/-1.0, 4.0+/-1.9, and 4.7+/-2.0 h, respectively). Intrarectal relative bioavailabilities of hydrochloride salt solution (57%) and Cinchona alkaloid mixture (62%) were similar.
CONCLUSION: Whatever the parenteral formulation of quinine, the blood concentration-time profiles of quinine were similar after intrarectal administration. Intrarectal administration of hydrochloride salt solution is a possible mode of quinine delivery in remote rural areas of Africa.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12610739     DOI: 10.1007/s00228-002-0546-2

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  9 in total

1.  APIS: a software for model identification, simulation and dosage regimen calculations in clinical and experimental pharmacokinetics.

Authors:  A Iliadis; A C Brown; M L Huggins
Journal:  Comput Methods Programs Biomed       Date:  1992-08       Impact factor: 5.428

2.  An open randomized clinical study of intrarectal versus infused Quinimax for the treatment of childhood cerebral malaria in Niger.

Authors:  H Barennes; J Munjakazi; F Verdier; F Clavier; E Pussard
Journal:  Trans R Soc Trop Med Hyg       Date:  1998 Jul-Aug       Impact factor: 2.184

Review 3.  Pharmacokinetics of rectal drug administration, Part I. General considerations and clinical applications of centrally acting drugs.

Authors:  E van Hoogdalem; A G de Boer; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1991-07       Impact factor: 6.447

Review 4.  Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.

Authors:  S Krishna; N J White
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

5.  Combination of quinine, quinidine and cinchonine for the treatment of acute falciparum malaria: correlation with the susceptibility of Plasmodium falciparum to the cinchona alkaloids in vitro.

Authors:  A Sowunmi; L A Salako; O J Laoye; A F Aderounmu
Journal:  Trans R Soc Trop Med Hyg       Date:  1990 Sep-Oct       Impact factor: 2.184

6.  The In vitro hepatic metabolism of quinine in mice, rats and dogs: comparison with human liver microsomes.

Authors:  X J Zhao; T Ishizaki
Journal:  J Pharmacol Exp Ther       Date:  1997-12       Impact factor: 4.030

7.  Activity of a combination of three cinchona bark alkaloids against Plasmodium falciparum in vitro.

Authors:  P Druilhe; O Brandicourt; T Chongsuphajaisiddhi; J Berthe
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

8.  Pharmacokinetics of quinine, quinidine and Cinchonine when given as combination.

Authors:  J Karbwang; D Bunnag; T Harinasuta; S Chittamas; J Berth; P Druilhe
Journal:  Southeast Asian J Trop Med Public Health       Date:  1992-12       Impact factor: 0.267

9.  Efficacy and pharmacokinetics of a new intrarectal quinine formulation in children with Plasmodium falciparum malaria.

Authors:  H Barennes; E Pussard; A Mahaman Sani; F Clavier; F Kahiatani; G Granic; D Henzel; L Ravinet; F Verdier
Journal:  Br J Clin Pharmacol       Date:  1996-05       Impact factor: 4.335

  9 in total
  5 in total

1.  Dose-dependent resorption of quinine after intrarectal administration to children with moderate Plasmodium falciparum malaria.

Authors:  Eric Pussard; Celine Straczek; Idrissa Kaboré; Auguste Bicaba; Tatiana Balima-Koussoube; Patrice Bouree; Hubert Barennes
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

2.  Safety and efficacy of rectal compared with intramuscular quinine for the early treatment of moderately severe malaria in children: randomised clinical trial.

Authors:  Hubert Barennes; Tatiana Balima-Koussoubé; Nicolas Nagot; Jean-Christophe Charpentier; Eric Pussard
Journal:  BMJ       Date:  2006-05-06

Review 3.  Artemisinins.

Authors:  C J Woodrow; R K Haynes; S Krishna
Journal:  Postgrad Med J       Date:  2005-02       Impact factor: 2.401

Review 4.  Intrarectal quinine for treating Plasmodium falciparum malaria: a systematic review.

Authors:  Michael Eisenhut; Aika Omari; Harriet G MacLehose
Journal:  Malar J       Date:  2005-05-18       Impact factor: 2.979

5.  Clinical pharmacokinetics of quinine and its relationship with treatment outcomes in children, pregnant women, and elderly patients, with uncomplicated and complicated malaria: a systematic review.

Authors:  Teerachat Saeheng; Kesara Na-Bangchang
Journal:  Malar J       Date:  2022-02-10       Impact factor: 2.979

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.